mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-06 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
1e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |